Skip to main content

Year: 2021

Independent Pilot Research Survey Demonstrates Else Products Dramatically Improved Major Feeding Related Disorders & Symptoms in Large Majority of Children

A more comprehensive study at final stages is aimed to be published in a peer reviewed medical journalIndependent pilot survey conducted among U.S. moms using Else Nutrition products with their children revealed dramatic improvement with up to complete recovery with feeding-related disorders and symptoms, including gastrointestinal problems, vomiting, skin rashes, spit up, and abnormal growth Initial analysis of the pilot data demonstrated over three quarters of mothers reported that the gastrointestinal, skin rashes, and bowel movement issues were resolved after switching their nutrition formula or supplement to Else Toddler or Else Kids Based upon these very positive early results Else will expand the research survey base.VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF)...

Continue reading

Islandsbanki hf.: Íslandsbanki taps ISB GB 25 1126 in private placement – correction

This is a correction of the announcement from 16:22 18.11.2021 GMT. The reason is a correction of the bonds name which is ISB GB 25 1126. Íslandsbanki hf. has today issued ISK 2,800m at a yield of 4,71% under its Domestic Bond Programme. The issue is a tap of the Banks previously issued green bond, ISB GB 25 1126. Following the tap, the total nominal amount issued will be ISK 6,700m. Settlement date is 25 November 2021. For further information:  Investor Relations – ir@islandsbanki.is.

Continue reading

On December 10, 2021, it shall be summoned the Extraordinary General Meeting of Shareholders

Upon initiative and resolution of the 18 November 2021 meeting of the Board of Directors, on December 10, 2021 it shall be summoned the Extraordinary General Meeting of shareholders of Rokiškio sūris AB which will take place in the company’s head office (Pramonės str. 3, Rokiskis. The company code: 173057512). Registration starts at 11 am and lasts until 11.45am. The general meeting’s accounting day – December 3, 2021.  Agenda: Regarding approval of the new wording of the Company’s Articles of Association. Election of the members of the Company’s Board of Directors.Draft resolutions prepared by the Board of Directors of AB Rokiskio suris 1. Regarding approval of the new wording of the Company’s Articles of Association.   Draft resolution:To approve the new wording of the Articles of Association of the joint-stock company Rokiškio...

Continue reading

SodexoMagic and Goodr Partner to Combat Food Insecurity and Waste

SodexoMagic and Goodr Partner to Combat Food Insecurity and WasteSodexoMagic and Goodr Partner to Combat Food Insecurity and WasteSodexoMagic and Goodr Partner to Combat Food Insecurity and WasteSodexoMagic and Goodr Partner to Combat Food Insecurity and WasteBeverly Hills, CA, Nov. 18, 2021 (GLOBE NEWSWIRE) — According to the USDA, 11.3 million U.S. households were food insecure in 2019 and 2020. The USDA also states that 30-40 percent of America’s food supply is wasted. Today, SodexoMagic announced a partnership with Goodr, a minority-owned, woman-led hunger relief and food waste management company. This partnership creates easy and ongoing access to fresh food at no cost and as well as a way forward for diverting edible food waste from SodexoMagic’s extensive nationwide food service operations. ...

Continue reading

Islandsbanki hf.: Íslandsbanki taps ISLA GB 25 1126 in private placement

Íslandsbanki hf. has today issued ISK 2,800m at a yield of 4,71% under its Domestic Bond Programme. The issue is a tap of the Banks previously issued green bond, ISLA GB 25 1126. Following the tap, the total nominal amount issued will be ISK 6,700m. Settlement date is 25 November 2021. For further information:  Investor Relations – ir@islandsbanki.is.

Continue reading

Valberedning utsedd inför årsstämma 2022 i Arcoma AB

18 november 2021 PRESSRELEASE Valberedning utsedd inför årsstämma 2022 i Arcoma AB I enlighet med årsstämmans beslut ska valberedningen inför årsstämman i Arcoma bestå av fyra ledamöter, representerande de tre största aktieägarna per den sista vardagen i september, samt styrelsens ordförande. Utövar inte aktieägaren sin rätt att utse ledamot i valberedningen ska den till röstetalet närmast följande största aktieägaren ha rätt att utse ledamot i valberedningen. Baserat på ovanstående har valberedningen inför årsstämman 2022 fastställts till att bestå av följande personer vilka tillsammans representerar cirka 60,29 procent av antalet aktier och röster i bolaget per utgången av september 2021:Bengt Julander, representerande Linc AB; Sören Lemonius, representerande Sunstone Life Science Ventures II K/S; Henrik Söderberg, representerande...

Continue reading

The Manufacturing Institute honors three outstanding women in manufacturing at BASF

FLORHAM PARK, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) — Three BASF leaders in manufacturing were among 130 women recognized nationally at The Manufacturing Institute’s ninth annual STEP Ahead Awards. Focusing on science, technology, engineering and production (STEP), the program recognizes women who exemplify leadership within their companies. Women who have demonstrated excellence and leadership in their careers across all levels of the manufacturing industry, from the factory floor to the executive level are selected for this honor, and the program further encourages award winners to mentor and support the next generation to pursue manufacturing careers. BASF’s award winners include:STEP Ahead Honoree: Elizabeth Monroe, Site Director in Beaumont, Texas STEP Ahead Honoree: Kristie Pickering, Utilities and Infrastructure Director...

Continue reading

Stellantis to Host Software Day 2021 on December 7

Stellantis to Host Software Day 2021 on December 7 AMSTERDAM, November 18, 2021 – Stellantis N.V. (NYSE / MTA / Euronext Paris: STLA) (“Stellantis”) announced today it will host Software Day 2021 on Tuesday, December 7, 2021 at 4:00 p.m. CET / 10:00 a.m. EST. Carlos Tavares, Chief Executive Officer, will share Stellantis’ software strategy for fully connected, clean, safe, personalized and affordable mobility that fits seamlessly into customers’ lives, magnifying our 14 iconic brands. Details for accessing the event are available under the Investors section of the Stellantis corporate website at www.stellantis.com. A recorded replay will be accessible under the Investors section of the Stellantis corporate website after the event. About Stellantis Stellantis is one of the world’s leading automakers and a mobility provider, guided...

Continue reading

New York State Approves Precipio’s HemeScreen for POL clinical use

New York Cancer & Blood POL will commence the use of HemeScreen in its laboratory NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from New York State’s Department of Health (NY DOH). Hemescreen can now be used by New York based physician-owned laboratories (POLs) who apply to run HemeScreen in their lab as a laboratory-developed test (LDT). New York State’s DOH is considered one of the strictest regulatory bodies in the US; laboratories interested in setting up and running new assays must submit comprehensive validation data demonstrating the accuracy, efficacy, reliability, and reproducibility of those assays. New York State’s DOH conducts an in-depth, rigorous analytical review...

Continue reading

AVVAA World Health Care Products, Inc. (OTC: AVVH) Announces Shareholder Updates

Proposed Dates for Merger and Recent Company Activities Houston, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AVVAA World Health Care Products, Inc. (OTC PINK: AVVH) provides shareholder updates for the following recent company activities. Mr. Miguel Sanchez, CEO, states, “We have successfully integrated our new management team into our company infrastructure and will continue to add new key executives in the coming months. During the past 60 days, we have finalized the company strategy to focus as the funder of choice for highly collateralized real estate first lien notes and real estate investments sourced and originated by the Gold Quest Group, LLC.  The company also plans to fund loans with other real estate brokers that provide opportunities that meet the company’s established funding criteria. Our management...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.